728

Google Web Search

Custom Search

Saturday, January 2, 2010

Telomere and telomerase assay

A telomere is a region of repetitive DNA at the end of a chromosome, which protects the end of the chromosome from deterioration. Its name is derived from the Greek nouns telos (τἐλος) "end" and merοs (μέρος, root: μερ-) "part".

Russian theorist Alexei Olovnikov was the first to recognize (1971) the problem of how chromosomes could replicate right to the tip, as such was impossible with replication in a 5' to 3' direction. To solve this and to accommodate Leonard Hayflick's idea of limited somatic cell division, Olovnikov suggested that DNA sequences would be lost in every replicative phase until they reached a critical level, at which point cell division would stop.

During cell division, the enzymes that duplicate the chromosome and its DNA cannot continue their duplication all the way to the end of the chromosome. If cells divided without telomeres, they would lose the ends of their chromosomes, and the necessary information they contain. (In 1972, James Watson named this phenomenon the "end replication problem".) The telomeres are disposable buffers blocking the ends of the chromosomes and are consumed during cell division and replenished by an enzyme, the telomerase reverse transcriptase.

Elizabeth Blackburn compared telomeres to the aglets (tips) on the ends of shoelaces that keep them from fraying.

In 1975–1977, Blackburn, working as a postdoctoral fellow at Yale University with Joseph Gall, discovered the unusual nature of telomeres, with their simple repeated DNA sequences composing chromosome ends. Their work was published in 1978. The telomere shortening mechanism normally limits cells to a fixed number of divisions, and animal studies suggest that this is responsible for aging on the cellular level and sets a limit on lifespans. Telomeres protect a cell's chromosomes from fusing with each other or rearranging—abnormalities which can lead to cancer—and so cells are normally destroyed when their telomeres are consumed. Most cancers are the result of "immortal" cells which have ways of evading this programmed destruction.

Elizabeth Blackburn, Carol Greider, and Jack Szostak were awarded the 2009 Nobel Prize in Physiology or Medicine for the discovery of how chromosomes are protected by telomeres and the enzyme telomerase.

Telomeres and telomerase: biological and clinical importance ...
(15) developed an assay for testing telomerase activity in cell extracts. Based on identification of telomerase mechanisms and properties, the telomere ...
www.clinchem.org/cgi/content/full/43/5/708

Telomere Length Analysis and In Vitro Telomerase Assay.

1 Introduction; 2 Materials and Methods; 2.1 Telomere Measurement; 2.2 Telomere Cloning; 2.3 TRAP Telomerase Assay; 3 Notes; References. Browse by Subject ...
www.springerprotocols.com/Abstract/doi/10.../1-59259-434-4:123

Facts about Telomeres and Telomerase

The following section will teach you the basics of telomeres and telomerase. It will also introduce you to the potential applications of current telomerase ...
www4.utsouthwestern.edu/cellbio/shay.../sw_facts.html

TRAP–LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules.
Its major function is to maintain the length of telomeric DNA by synthesizing telomeric DNA repeats, and its enzymatic activity is assayed by means of the ...
linkinghub.elsevier.com/retrieve/pii/S0003269708002960

Telomeres and Telomerase: The Cellular Timekeepers

The telomeres appear to be the cellular timekeepers, but are they related to human aging?
www.senescence.info/telomeres.html

Effect of Telomere and Telomerase Interactive Agents on Human Tumor and Normal Cell Lines.
The cytotoxic effect of telomere and telomerase interactive agents against normal human marrow cells in the colony-forming assay showed the same range of ...
clincancerres.aacrjournals.org/content/6/3/987.full

Cell Research - Telomere and telomerase in oncology
Shortening of the telomeric DNA at the chromosome ends is presumed to limit the lifespan of... Telomere, telomerase, cancer, telomerase assay, inhibitor ...
www.nature.com

Telomeres and telomerase — Genes & Development
Cdc13p (gray) and Est1 (purple) may recruit telomerase to the telomeric 3′ end in ..... (1995) An in vitro assay for Saccharomyces telomerase requires EST1. ...
genesdev.cshlp.org/content/13/18/2353.full

Telomerase Assay in Renal Cancer

Bacchetti, S. and Counter, C. M. (1995) Telomeres and telomerase in human cancer. ...quantitative nonisotopic assay for telomerase activity in humantumors. ...
www.springerprotocols.com/Abstract/doi/10.1385/1-59259-144-2:05

Introduction to Telomeres and Telomerase

Author(s): Michael C. Bibby

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:01; Page Range: 1-12

Abstract | Full Text | PDF (81K)

Detection of Chromosome Ends by Telomere FISH

Author(s): Harry Scherthan

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:13; Page Range: 13-31

Abstract | Full Text | PDF (117K)

Telomere Length Distribution: Digital Image Processing and Statistical Analysis

Author(s): Jean-Patrick Pommier, Laure Sabatier

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:33; Page Range: 33-63

Abstract | Full Text | PDF (351K)

Analysis of Telomerase RNA Gene Expression by In Situ Hybridization

Author(s): W. Nicol Keith, Joseph Sarvesvaran, Martin Downey

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:65; Page Range: 65-81

Abstract | Full Text | PDF (132K)

Relative Gene Expression in Normal and Tumor Tissue by Quantitative RT-PCR

Author(s): Dennis S. Salonga, Kathleen D. Danenberg, Jean Grem, Ji Min Park, Peter V. Danenberg

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:83; Page Range: 83-98

Abstract | Full Text | PDF (138K)

Quantitative Detection of Telomerase Components by Real-Time, Online RT-PCR Analysis with the LightCycler

Author(s): Thomas Emrich, Sheng-Yung Chang, Gerlinde Karl, Birgit Panzinger, Chris Santini

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:99; Page Range: 99-108

Abstract | Full Text | PDF (98K)

Standard TRAP Assay

Author(s): Angelika M. Burger

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:109; Page Range: 109-124

Abstract | Full Text | PDF (131K)

Stretch PCR Assay

Author(s): Jun-ichi Nakayama, Fuyuki Ishikawa

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:125; Page Range: 125-136

Abstract | Full Text | PDF (110K)

Fluorescent Detection of Telomerase Activity

Author(s): Wade K. Aldous, Amber J. Marean, Mary J. DeHart, Katherine H. Moore

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:137; Page Range: 137-146

Abstract | Full Text | PDF (99K)

Nonradioactive Detection of Telomerase Activity Using a PCR-ELISA-Based Telomeric Repeat Amplification Protocol

Author(s): Thomas Emrich, Gerlinde Karl

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:147; Page Range: 147-158

Abstract | Full Text | PDF (123K)

In Situ TRAP Assay Detection of Telomerase Activity in Cytological Preparations

Author(s): Kazuma Ohyashiki, Junko H. Ohyashiki

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:159; Page Range: 159-164

Abstract | Full Text | PDF (143K)

Biotinylated Primer for Detecting Telomerase Activity Without Amplification

Author(s): Daekyu Sun

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:165; Page Range: 165-171

Abstract | Full Text | PDF (81K)

Whole-Cell and Microcell Fusion for the Identification of Natural Regulators of Telomerase

Author(s): Henriette Gourdeau, Marsha D. Speevak, Lucie Jetté, Mario Chevrette

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:173; Page Range: 173-195

Abstract | Full Text | PDF (145K)

Screening with COMPARE Analysis forTelomerase Inhibitors

Author(s): Imad Naasani, Takao Yamori, Takashi Tsuruo

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:197; Page Range: 197-207

Abstract | Full Text | PDF (125K)

Telomerase as a Therapeutic Target: Therapeutic Potential of Telomerase Inhibitors

Author(s): John A. Double

Pub. Date: Mar-01-2002; DOI:10.1385/1-59259-189-2:209; Page Range: 209-216

Abstract | Full Text | PDF (71K)

Methods of Telomerase Inhibition
Additionally, methods are outlined in this chapter for determining the effectiveness oftelomerase inhibition through TRAP assays or assessment of telomere ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC2423206/

No comments: